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TheInterlabProject isaunivety-industyjointprojectrecentlyfundedbytheItaliangovernmentaspartoftheim-
prwement ofthe Italian research infrastructure; among itsshort-term goals arethe unpiementation ofdata banksof
bimedicalinterestandthespreadofinfonnatictoolsforbimedialreseach. Resultsofbothlong-termassaysofcar-
cinogenidtyinrodentsandAort-terminvibuandinWwotestsofgeotsicity am relevantforawidebodyofusers, nging
fromcagenesis bl atoriestoind iesandge lbelethemosta iateways
ofspreadinginformation ontheseexperiments, adetailedanaly on information recordedinavailabl databases has
beencarriedout.Furthernwmre, thecontentsofthemostknowndatabaseshavebeencompared, withrespecttoaspecific
compound, toevaluateboththeoverallreliability ofthesesystems, comparedtolongerandmorecomplec assessments
carried out manually startingfrombibliographic searches, andthelevelofconcordanceamongthem.
Introduction
Telematics, the synergic useofinformatics andcommunica-
tion systems to improve the transmission and sharing ofdata
amongcomputers at aninternationallevel, hashad an enormous
impact ontheresearchenvironment. Inrecent years, anumber
ofnetworkshavebeensetup, and manyon-linedatabankshave
beencreated. Toxicityresearch, inparticularthatrelating to car-
cinogenicity and genotoxicity, have become involved and
somehow benefited from these initiatives. Moreover, the
dramatic improvementofelectronictechnologies thathasledto





Thus, atthe moment, anumber ofdifferent sources for car-
cinogenicity andgenotoxicity dataisavailable. Iftheformerare
relatively few, thisis notthe caseforthelatter, since many new
results are continuously being published. Availability ofthese
tools totheendusershasbeenguaranteed by meansofanumber
ofsystems, rangingfromliterature reports topersonal computer
software, on-linedatabanksandCD-ROM(compactdisk-read-
only memory).
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institutes do not always become involved in creating these








Thepromoting institutions forthe project are the National In-
stituteforCancerResearch (IST) ofGenoa; theInterUniversi-
ty Center for Cancer Research (CIRC), grouping five Italian
universities; andAnsaldoSpA, anItalianleaderininformation
systems. Theprojectwasfundedona2-yearschemeinJune 1989
by the ItalianMinistry forUniversity and ScientificandTech-
nological Research, with the goal of improving the Italian
research infrastructure.





workhasbeen setupto allow foreasyand steady communica-ROMANO ETAL.
tionamonginstitutes, whoseresearchers canexchangemessages
bymeansofanelectronicmail system. Itisplannedthat, inthe
future, abulletinboardsystemwillalsobeavailable, aswellas
acustom service forbibliographic searches.




data were available. Personal computer versions of these
databases are being created to help researchers maintain their
collections ofbiological materialsandguarantee asteady flow
ofup-to-date information.
Among the main design criteria, two areparticularly worth
mentioningbecause they give the system its specificity. These

















data being inserted canbecarriedoutby the systemas well.
Moreover, sincetherelationalapproachleadstospecificdata
structures, any ad hoc queries, specifying which terms canbe
searchedandinwhichcontext, mustbedefined, andadhocap-
plicative software, aimed to the creation ofthe user interface,
mustbedeveloped.
The databases have been implemented on a Unix-based
microcomputer, andtherelationaldatabawmanagementsystem
Oracle, a commercial software available worldwide, has been
adopted. Essentially, Oraclehasbeenchosenforitswidespec-
trum ofversions, ranging from personal computers to main-
frames, andforitsgoodmodularityandportabilitythatmakethe
creation ofdatabase versions for other computers and ofnew
releases easierandquicker.
Theuserinterface isalwaysafundamentalpartofthesystem
because it determines the real accessibility ofthedata. In our
case, italsohadtobeeasytouseandasclearaspossibleforpeo-
ple without specific skills in informatics. Ithas beencarefully
designedforgeneralfeatures, whicharevalidforalltheapplica-
tions, andforspecific features, whicharevalidonlyinspecific
contexts, such as insertion and query.
ApartfromhavingmaskedtheUnixoperatingsystemandSQL
(Structured Query Language, the standard queryfhnguage for
relationalsystems) totheendusers, extensiveuseofmenusand
ofcontextualhelpshasbeenmade. Furthermore, tosimplifythe
interaction between the user and the applications, a limited
numberoffunctionkeysisusedand, whenpossible, thewords
takenfromtheinformaticsjargon, likefield,record, andblock,
havebeen substituted with more widely usedterms.
Amonguserinterfacespecificfeatures, particularly relevant
are those devoted to the optimization ofthe use ofcontrolled
vocabularies, suchastheextensiveuseofmnemonic codes in-
steadofthecompletetermsandanautomaticdisplayofthe list
oftheavailableitems. Moreover, dataarevalidatedduringinser-
tion, queries are defined according to high-level macro-
information, anddataarepresented incoherent subsets.
Until now, three databases have been implemented and are
availableon-line. Thefirstonerelatestocelllines(CLDB), the
secondtoHLA-typedB-lymphoblastoidcelllines(BLDB),and
thethirdtooligonucleotides (MPDB). CLDB containsdataon
720celllinesavailableinItalianlaboratories. Morethanthe60%
oftheselinesareoriginal,thatis,notdescribedinanyothercom-









vocabularies have been defined for most information. Among
them are species and relative strains, morphologies, tumors,
transformingagents, applications, and functions.
Searches canbecarriedoutusingthreedifferentapproaches:
by name, byorigin, andby function. Usingthe firstapproach,
the search can be conditioned on the basis of the name, the
presence in a given catalog and/orthe identification code in a
catalog. Thequerybyorigincanbeusedtoretrievecelllineshav-
inggivenspecies, strain, tissue, tumor, andpathology. Finally,
thequerybyfunctionrelatestocelllinesapplicationsandspecific
functions. A new approach, based on a query related to the
transforming agent, willbeaddedinthenearfuture. Following
theretrievalofdesiredcelllines, information canbedisplayed





BLDB contains data on approximately 750 B-lymphoblastoid
linesavailablefromthelaboratoriesoftheEuropeanCollection
forBiomedical Research (Essen, Germany andGenoa, Italy).
DatafromtwootherEuropeancollections arebeingadded. At
the moment, the prototype of MPDB contains data on oligo-
nucleotidesproducedbytheinternalserviceoftheNationalIn-









floppy disks ortapes, attimes with someadhoc software, that
allowsfortheirmanagement. Finally, someareavailabletothe
endusersonly in aprintedformat.
114ANALYSIS OF CARCINOGENICITYAND GEN'OTOXICITYDATABASES
Often, whenbiologistswanttosearchthesedatabases, theyare
not fully aware ofthe main goals and specificities ofeach of
them. Thedatabases includedinthisanalysishavebeenchosen
on the basis of their availability and relevance, relevance
measuredintermsofquantityofdata,promotinginstitution, in-
ternational agencies involvement and geographic origin, and
havebeenanalyzedfromthepointofviewoftheseunpracticed
biologists.
In regard to on-line databases, Registry ofToxic Effects of
Chemical Substances (RTECS) (2), Chemical Carcinogenesis
ResearchInformationSystem(CCRIS) (3), andEnvironmental
Chemical Data and Information Network (ECDIN) (3) have
been considered. RTECS is a factual, nonbibliographic data
bank, builtandmaintainedbytheNationalInstituteforOccupa-
tional Safety and Health (NIOSH) and hosted by a number of
well-known host computers in the United States, Europe, and
Australia; it contains mutagenesis studies on nearly 10,000
substancesandcarcinogenesis studiesonabout3,400substances.
CCRIS ishostedbyChemical InformationSystems, Inc. (CIS)
and the National Library ofMedicine (NLM); itcontains car-
cinogenicity, co-carcinogenicity, andmutagenicitydataon 1,269
substances. ECDIN is afactual databank, created by theJoint
Research Centre (JRC) of the Commission of the European









Carcinogenic Potency Database (CPDB) (5) andtheGene-Tox
Carcinogen Database (CTJX2DB) (6) forcarcinogenicity andthe
Genetic Activity Profile Database (GAP) (7,8) and the GEN
Database (GEN) (9) forgenotoxicity. CPDB contains standar-
dizeddataon4000animalexperimentswithabout 1000chemical
compounds. GTCDB contains data on more than 500 selected
chemicals. GAP provides activity profiles and corresponding
listings ofdataandreferences foreachchemical analyzed. Two
datasetsareincludedintheGAPsoftware: onerelatedtotheIn-
ternational Agency forResearchonCancer (IARC)(277 agents)
and one related to the U.S. Environmental Protection Agency
(EPA) (167 agents).
Selectionofdatafortheanalysishasbeencarriedoutmanually
forCPDB andGJXDB and onthebasis ofad hocmanagement
software distributed with the databases forGAP and GEN.
Objectives and Results
The research was mainly aimed ata) comparing thetypes of
information recorded ineach database, b) determining acom-
mon, basic data set, c) evaluating data overlapping between
databases, d)evaluating generalagreement/disagreement among




Adetailedanalysis oninformation recorded inavailable car-
cinogenicity databases hasbeencarriedout. Datahavebeen sub-
dividedintotwogroups, devoted, respectively, tothedescription
ofthe compound and the experiments, and each ofthese into
many coherentsubgroups (Tables 1 and2).
Asfarasthedescriptionofthecompound(Table 1)isconcern-





all. Furthermore, recognizedevaluations, suchas[ARCandNa-
tional Cancer Institute/National Toxicology Program
(NCI/NTP) classifications, aregenerally neitherlistednorsuf-
ficientlyhighlighted. Supplementaryinformation, whichcould
be relevant for accessing compound data on the basis of the






in a number ofdifferent, nonstandardized ways. This is par-
ticularly evident forinformation relatedtoexperimental design
and results. Otherinformation on results, such astumor laten-
cy, which is relevantforriskassessment, are normally absent.
Quantitative evaluations are rarely present and bibliographic
references arenot standardized.
Dataoverlapping hasbeenevaluatedby comparing citations
andsinglelong-termanimalexperiments reportedbyeachcar-
cinogenicity database. To this end, a specific compound
(benzene) hasbeenchosenandallrelatedinformationhasbeen
selected from the databases and analyzed (Tables 3-5). Every
carcinogenicity study singly identifiable on the basis of bib-
liographic reference, species, strain, sexandrouteofadministra-
tion has been considered as a separate experiment. Data show
thatNCI/NTPexperimentsarenormallylisted, evenifnotallthe
experiments that were carried out in this context are reported
(Table 3). Somemisunderstanding canarise inregard toIARC
monographs, whichbeing surveys, do not list any original ex-
periment: intwocasesamonograph wasreportedasanoriginal
referencefortheexperiment, while, intheothers, referencesto
original experimentsreportedalsoinanIARC monographwere
given. Apart from NCI/NTP technical reports and IARC
monographs, databases reported, inmostcases, agreatnumber
oforiginal experiments (ranging from7to 12), buttheoverlap
was poor: only 5 outof37 experiments were reported inmore
thanonedatabase. Totalexperiment redundancy (stillexcluding
those ofthe NCI/NTP and IARC), corresponding to the per-
centage ofexperiments reported morethan once, is thus about
14%.
A similar situationcanbeshownbyanalyzing citations only
(Table 4). Inthiscase, since ambiguities possibly arising from
differentinterpretationofresultsshowninpapersareabsent, data
are more readable. Total redundancy, corresponding to the
percentageofreferencescited inmorethanonedatabase, isca.
22%. Citations andciting databases arereported in Table 5.
The lowredundancy thathasbeenfoundcanbeexplainedon
thebasis ofmanydifferentreasons. Onepossibleexplanation is
that more than one paper can present and discuss the same
original experiment, possibly with some marginal updating or
deeperanalysis. Inthis case, the samedatacouldbe inserted in
115ROMANO ETAL
Table 1. Compound identification dataincarcinogenicit databases.
Databasea
CPDB CCRIS RTECS GTCDB BL-DB ECDIN HypDB
Identification
Name X X X X X X X
Synonymsandtrade names X X X X X
CASregistry number X X X X X X X
Otherinternational reference numbers X X X
and names
Chemical properties
Chemical formula X X X X
Formula mass X
Chemical structure Xb Xb Xb X
Otherphysicochemical parameters xc Xd xe
Pharmacokinetics X
Overall evaluation
Ownevaluation X X X X
IARC evaluation X
NCI/NTP evaluation X X
Otherevaluations xf X
Supplementary information
Chemical class X X
Majoruses X X X X
Otherkey words X X
Abbreviations: CPDB, Carcinogenic Potency Database; CCRIS, Chemical Carcinogenesis Research Information System; RTECS, Registry ofToxic Effects of
Chemical Substances; GTCDB, Gene-ToxCarcinogenDatabase; BL-DB, biological database; ECDIN, Environmental Chemical DataandInformation Network;
HypDB, hypothetical database.




eExamples are ionic status, structural alerts, hydrophilicity/phobicity.
fRTECS toxic dose.
Ilble2. Experiment description dataincarcinogenicit databases.
Database
CPDB CCRIS RTECS GTCDB BL-DB ECDIN HypDB
Animals
Species X X X X X Xb X
Strain X X X X X Xb X
Sex X X X X X X X
Other information xc
Experimental design
Route X X X X X X X
Doses X Xd xe X X
Duration X XI Xe X X X g X
Sample size X X X
Compound's purity X
Results
Targetorgan X Xh xi Xh Xi Xh X
Tumortype X Xh Xh Xi Xh X
Tumor incidence X Xi X X
Tumorlatency X X
Evaluation
Qualitative Xk X Xi X X X
Quantitative X Xe X X
Bibliography X X X X X X X
Abbreviations: CPDB,CarcinogenicPtencyDatabase; CCRIS,ChemicalCarinogenesisResearchInformationSystem; RTECS,RegistryofToxicEffectsofChemical
Substances; GICDB, Gene-ToxCarcinogenDatabase; BL-DB, Biological Database; ECDIN, Environmental Chemical DataandInformation Network; HypDB,
hypothetical database.
aCCRISand RrECS areon-linedatabanks.
bFree-textdescription ofspecies and strain.
cAge, weight.
dFree-textdescriptionofnonstandardizeddosesandduration.
cFree-textdescription ofdurationandeitherlowestdosage inducingasignificant increase intumorincidenceordosageinducingasignificant increase in tumor
incidence.
fSeparate description ofsingledose, total dose, and commentondose.
gSeparatedescription offrequency anddurationofadministration.
hFree-text descriptionoftarget organand tumor.
'Free-textdescription oftargetorgan, tumor, andeffects.
'Tabular formatand short textdescription.
kAuthor's opinion, ifstated.
H6ANALYSIS OF CARCINOGENICJYAND GENOTOXICITYDATABASES
¶kble3. ReportedeiperimentsandoverlapincdrdngeniclyabS: benzene(CAS no. 7143-2).
Overlapd
NTP' IARCb Total (uniques)' RTECS CCRIS CPDB GTCDB ECDIN
RTECS 1 3e 12 (7) - 0 2 2 1
CCRIS 4 3 1 (1) 0 - 0 0 0
CPDB 4 4' 10 (8) 2 0 - 0 0
GTCDB 4 2 12(10) 2 0 0 - 0
ECDIN 0 6e 7 (6) 1 0 0 0 -
Reportedexperiments: 37 Redundancy: 5/37 (- 14%)
Abbreviations: CPDB, Carcinogenic Potency Database; CCRIS, Chemical Carcinogenesis ResearchInformationSystem(on-linedatabank); RTECS, Registry
ofToxicEffectsofChemicalSubstances(on-linedatabank); GTCDB, Gene-ToxCarcinogenDatabase; ECDIN, EnvironmentalChemical DataandInformative
Network (on-line databank).
'Numberofexperiments reported fromtheNCI/NTPTechnical Report.
bNumberofexperiments reported fromIARCMonographs asanoriginal sourceofdata.




Table4. Citationsreportedandoverlapincardnogenicity databases: benzene(CASno. 71-43-2).
Overlapd
NTP' LARCb Total (uniques)c RTECS CCRIS CPDB GTCDB ECDIN
RTECS Yes 2e 9(5) - 0 1 2 1
CCRIS Yes Yes 1(1) 0 - 0 0 0
CPDB Yes 2e 4(3) 1 0 - 0 0
GTCDB Yes Yes 4(2) 2 0 0 - 0
ECDIN No 3c 4(3) 1 0 0 0 -
Reportedcitations: 18 Redundancy: 4/18(- 22%)
Abbreviations: CPDB, Carcinogenic PotencyDatabase; CCRIS, ChemicalCarcinogenesis ResearchInformationSystem(on-linedatabank); RTECS, Registry
ofToxicEffectsofChemical Substances (on-linedatabank);GTCDB, Gene-ToxCarcinogenDatabase; ECDIN, Environmental Chemical DataandInformative
Network (on-line databank).
'Citation ofNCI/NTP Technical Report.
'Citation ofIARCMonographs. "Yes" indicates thatthemonographs were useddirectly as a sourceofinformation.
cTotal numberofcitationsand, inparentheses, thenumberofcitations hatarenotreported inanyotherdatabase, excludingNCI/NTPTechnicalReportand ARC
Monographs.
dNumber ofcitations reported by eachcoupleofdatabases.




Maltoni etal. (10) RTECS, GTCDB
Maltoni etal. (11) CPDB
Baldwin etal. (12) RTECS
Snyderetal. (13) GTCDB
Kirschbaum etal. (14) ECDIN, IARC
Hiraki etal. (15) ECDIN
Cronkite etal. (16) RTECS
Snyder etal. (17) CPDB
Lignac (18) RTECS
Lignac (19) RTECS, ECDIN, IARC
Maltoni and Scarnato (20) RTECS, CPDB, IARC
Maltoni etal. (21) CCRIS
Sellakumaretal. (22) RTECS
Amiel (23) ECDIN, IARC
Snyderetal. (24) CPDB, IARC
Cronkite etal. (25) RTECS, GTCDB
Stoner etal. (26) RTECS
Goldstein etal. (27) GTCDB
Abbreviations: LARC, InternationalAgency forResearchonCancer; CPDB,
CarcinogenicPotencyDatabase; CCRIS, ChemicalCarcinogenesisResearch
InformationSystem; RTECS, RegistryofToxicEffectsofChemicalSubstane;
GTCDB, Gene-Tox CarcinogenDatabase; ECDIN, Environmental Chemical
DataandInformation Network.
differentdatabases withdifferentreferences. Anotherexplana-







to give end users sufficient data without reading the original
papers. Fromthispointofview, thecurrentsituationcouldbe











only by chromosomal damage assays. More specifically,
relatively few in vitro DNA damage short-term experiments
showaclearlynegativepattern, withpositiveresultsconstant-




Table6. Genotoxicity testsforbenzene (CAS no. 7143-2) asreportedbythe
Genetic Activity Profile database (IARC dataset).'
In utro
In vitro with activation In wvo Total
- + + - + %+ - + + - +%
DNAdamage 8 3 27 5 0 0 13 3 19
Chromosomal 28 7 20 16 7 30 4 23 85 48 37 44
damage
Mutation 47 9 16 47 4 8 94 13 12
Total 83 19 19 68 11 14 4 23 85 155 53 25
aForeachendpoint, thetotal numberofpositiveandnegativeresults listed in
theGenetic Activity Profiledatabase (GAP) isreported, togetherwiththepercen-
tageofpositiveresults. Rowandcolumntotalsarereported. Transibrnationassays
and twoothernonclassifiable assays have notbeenconsidered. Relatively few
weakresponses, bothpositiveand negative, have beenincluded. Inconclusive
results have beendiscarded.
Table 7. Comparison amonggenotoxicity databases:
benzene (CAS no. 7143-2).'
In vtro
Invtro withactivation In wvo Total
- + + - + %+ - + + - +%
DNA damage
GAP 8 3 27 5 0 0 13 3 19
ECDIN 10 2 17 1 0 0 11 2 15
Chromosomal damage
GAP 28 7 20 16 7 30 4 23 85 48 37 44
ECDIN 1 0 0 2 12 86 3 12 80
Mutation
GAP 47 9 16 47 4 8 94 13 12
ECDIN 9 0 0 1 0 0 10 0 0
CCRIS 3 0 0 5 0 0 8 0 0
Abbreviations: GAP, GeneticActivity Profiledatabase; ECDIN, Environmen-
tal Chemical DataandInformationNetwork; CCRIS, ChemicalCarcinogenesis
Research Information System.
'For each end point, the total number ofpositive and negative results are
reported together with the percentage ofpositive results. Row totals are also
reported. ForGAPdata, seeTable6. NoDNAdamageandchromosomaldamage
data wereavailable onCCRIS. RTECS was notconsideredbecause itdoes not
reporteffects on single genotoxicity tests.
Table 8 Comparison among genotoxicity databases:
benzene (CAS no. 7143-2).'
In vitro In vio
- I + - I +
Chromosomal damage
GAP 13 5 4 2 0 5
GEN 1 0 0 0 1 2
Mutation
GAP 26 6 2
GEN 2 1 2
Abbreviations: GAP, GeneticActivity Profiledatabase; GEN, GENdatabase.
aFor each endpoint, total negative, inconclusive (I), andpositive figures are
reported. Eachtestsystemhas beenconsideredonly onceandifthe sametest was
performed in more than oneexperiment, anoverall evaluationis reported. For
GAPdata, the testhas been considered negative when less than25% ofresults
were positive and otherwise positive. GEN data are already listed as overall
evaluations in the database.
forin vivotests; thepercentageofpositiveresults rangesfrom20
to 30% in the former case and attains 85% in the second, with
ageneral mean of44%. Finally, mutation experiments show a
clearly negative behavior, with percentages ofpositive results
ranging from 14 to 19%.
Table9. ComparisonbetweenGeneticActivity Profile(GAP)databaseand
bibliographic searches (BS): benzene (CAS no. 71-43-2).a
In vitro In wvo Total
- + %+ - + %+ - + %+
DNA damage
GAP 13 3 19 13 3 19
BS 6 7 54 2 10 83 8 17 68
Chromosomal damage
GAP 44 14 24 4 23 85 48 37 44
BS 16 16 50 11 83 88 27 99 79
Mutation
GAP 47 9 16 47 9 16
BS 46 19 29 1 0 0 47 19 29
Total
GAP 104 26 20 4 23 85 108 49 31
BS 68 42 38 14 93 87 82 135 62
'Foreachendpoint, thetotalnumberofnegativeandpositiveresultslistedin
databasesarereported, togetherwiththepercentageofpositiveresults. Rowand
column totals are reported as well. For GAP data see Table 6. Data from
bibliographicsearchesarecourtesyofS. GrillliandA. M. ColaccioftheInstitute
ofOncologyoftheUniversity ofBologna, Italy.
Theseresultsaresubstantially confirmedbycomparisonwith
other databases (Tables 7 and 8), although fewer data are
available. AlthoughRTECScannotbecomparedbecauseitdoes
notreportresultsofsingleexperiments,itispossibleforECDIN
and CCRIS, and data available confirm benzene behavior for
both mutationandchromosomal damageassays.
To compare GAP and GEN data, the former must be re-
examined. Infact, insteadoflisting the results ofallpublished
experiments, GEN reports an overall evaluation of all ex-
perimentsrelatedtoonespecificassay. Re-examinationofGAP
datahasbeencarriedoutconsideringatestnegativewhenmore
than 75% ofthe results were negative, inconclusive when less




This substantial consistency of experiments on benzene
reported on many different databases demonstrates that, al-
thoughsomeofthemarelackingforparticulartpesoftests, end
userscantrustdatabasestosimplify, improve, andspeeduptheir
work. The great differences existing among databases, never-














only 27 and 58, respectively. The overall ratio ofpositive ex-
perimentsishigherforBSthanforGAP(62%against31%). This
is only partly due to the presence of 10clearly positive in vivo
DNA damage experiments. In fact, there is a constant higher
ratioofpositiveresults inBSthan inGAPforall groupsofex-
periments. Thisdoesnotmodifyexistingdifferencesbetweenin







quality could be achieved.
Conclusions
Typesofinformationrecordedintosixdifferentcarcinogenici-
tydatabases, threeofwhicharealready available on-line, have
been compared to verify ifa common format was used, thus
allowing datainterchange, andtoidentify abasicdataset. This
comparison showed anextremelydiversified situation inwhich
thephysicochemical characterizationofchemicalcompounds,
as well as overall evaluations andinter-databasereferences are




experiments on benzene and of respective bibliographic re-
ferences reportedbycarcinogenicitydatabases showedthateach
of them lists many original works not reported by any other
database, thus producing a low redundancy ofreferences. Ex-
planations forthisunexpectedresulthavebeenproposed, though
this diversified reality is actually whatappears toend users.
Results reported on benzene by four different genotoxicity
databaseshavebeencompared toverify thegeneral agreement
among them and their overall reliability. Results showed the
same, well-known, globalactivityprofile forallthedatabases,
though only GAP seemed to present data on all different test
systems.
Finally, GAPgenotoxicity results forbenzenehavebeencom-
paredwithdataobtainedbymeansofacontinuousbibliographic
search. This comparison showed, on one hand, that GAP
substantially presents atrueimageofreality and, on theother,
thatalsoforagooddatabase, agreatpercentageofshort-termex-
periments can still bemissed.
In conclusion, this work shows thata) databases can be ex-
tremelyusefulforresearchers inthefieldsofcarcinogenicity and




ly amongdatabases, c) theavailability ofmany databases does
nothelp theend users, instead itcancreate misunderstanding,
overestimation, orconfusion, andd) aneffort shouldbe made
todefineacommonreferenceformat, identify, andsupportthe
bestdatabases, evenbymultiplying theinputnodes, toachieve
database exhaustiveness.
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